Janusz Jankowski, MD, PhD, FRCP
Reflux, Barrett's esophagus, GI cancer prevention, fatty liver, and evidence-heavy gastroenterology
At a glance
- Visit type
- In person
- Years in practice
- 42
- New patients
- Accepting patients
- Languages
- English
Practice
About
Janusz Jankowski is a consultant gastroenterologist with more than four decades in gastroenterology, cancer prevention, nutrition, and clinical trials. His training spans Glasgow, London, Oxford, Dundee, and Cambridge, and his research profile is unusually deep for a Dubai clinic: the AspECT trial in The Lancet, later work on Barrett's surveillance, 447 ResearchGate-listed publications, and 30,000+ citations. At Biongevity, that background is most relevant for reflux, Barrett's esophagus, GI cancer prevention, fatty liver, and metabolic digestive risk.
Approach
Signature approach
Jankowski brings a prevention-first gastroenterology lens. For reflux, Barrett's esophagus, family GI-cancer risk, obesity, or fatty-liver patterns, the visit is about understanding trajectory: what needs surveillance, what can be modified, and where chemoprevention, nutrition, endoscopy, or metabolic care should sit. He is especially useful when trial-level evidence needs to become practical GI risk planning.
What sets them apart
- AspECT trial leadership. His Barrett's esophagus chemoprevention work helped define how high-dose PPI and aspirin strategies are discussed for the right patients.
- Research depth. 447 listed publications, 30,000+ citations, major GI oncology textbook work, and $100M+ in grant history give him rare academic weight in a clinic setting.
- GI cancer prevention focus. Reflux, Barrett's, nutrition, obesity, fatty liver, and surveillance strategy all connect to a coherent prevention focus.
Focus
Specialties
Who they see
Conditions treated
- Chronic acid reflux / heartburnGastroesophageal reflux disease (GERD)
- Barrett's esophagusBarrett's esophagus (intestinal metaplasia)
- Concern about esophageal or GI cancer riskGI cancer prevention and screening
- Fatty liver diseaseNon-alcoholic fatty liver disease (NAFLD) / metabolic-associated steatotic liver disease (MASLD)
- Digestive issues needing endoscopyEndoscopic management of gastrointestinal diseases
- Diet and nutrition for cancer preventionNutritional oncology / chemoprevention
Training
Education
- MB ChBUniversity of Glasgow
- PhD, ResearchUniversity of London (1996)
- MD, ResearchUniversity of Dundee (1995)
- PCMEUniversity of Cambridge
- MSc, Clinical TrialsUniversity of Oxford (2008)
Board certifications
- FRCP
Royal College of Physicians (London)
Senior fellowship at the UK's principal physicians' college, awarded to consultants with sustained achievement in clinical practice and research.
- FRCP(E)
Royal College of Physicians (Edinburgh)
Fellowship at the Edinburgh college, granted to physicians who have made significant contributions to medicine.
- FACG
American College of Gastroenterology
Fellowship from the leading US gastroenterology society, recognizing demonstrated excellence in clinical practice and research.
Additional certifications
- AGAF (AGA Fellow)
American Gastroenterological Association
Fellowship from the American Gastroenterological Association, recognizing outstanding contributions to gastroenterology research or education.
- SFHEA (Senior Fellow)
Higher Education Academy (UK)
Senior fellowship from the UK's higher education professional body, recognizing sustained impact on university teaching and supervision.
Protocols
- Upper gi endoscopy
- Barrett's esophagus surveillance
- Chemoprevention protocols (ppi + aspirin)
- Nutritional cancer prevention programs
- Precision gastroenterology diagnostics
- Microbiome analysis
Published work
Books
- 2024
- Wiley, 2024
Publications
- The Lancet, 2018
- Barrett's Oesophagus Surveillance versus Endoscopy at Need Study (BOSS): A Randomized Controlled TrialGastroenterology, 2025
- Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett's esophagusNature Genetics, 2012
- Polymorphisms Near TBX5 and GDF7 are Associated with Increased Risk for Barrett's EsophagusGastroenterology, 2014
- Diagnosis and management of Barrett's oesophagusBMJ, 2010
Elsewhere
Profiles
Before You Book
- Care focus. Reflux, Barrett's esophagus, GI cancer risk, fatty liver, or digestive prevention questions that benefit from a research-heavy specialist.
- Dubai consults. Patient visits are in person in Dubai, with additional academic and advisory roles outside the clinic.
- Availability may vary. He is also publicly listed with Clemenceau Medical Center Dubai, so confirm Biongevity appointment timing before planning around him.
Verification
- Profile updated
- Credentials checked
- Affiliations verified
Primary sourcehttps://biongevity.com/prof-dr-janusz-jankowski-md-phd/
Where a detail is missing, it means we have not verified it—not that the answer is no. Directory listings are for informational purposes only. Inclusion does not constitute endorsement. Verify credentials and qualifications independently.